Blood Screening Market 2020 Growth Strategy| Global Industry Share, Future Trends, Historical Analysis, Competitive Landscape and Regional Forecast 2024

"Increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens are driving the overall growth of the blood screening market"

The blood screening market is projected to reach USD 3.3 billion by 2024 from USD 2.2 billion in 2019, at a CAGR of 8.7%. Growth in this market is driven by the increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens. Technological advancements and developing economies are expected to present opportunities for growth for players in the blood screening market. However, the need to reduce blood screening prices is a major factor in challenging market growth.

#Download Free PDF Sample Brochure of report Global Blood Screening Market 2020 across with 166 Pages and in-depth TOC Analysis @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=345414

Prominent players in the blood screening market include Grifols (Spain), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (US), BioM?rieux (France), Bio-Rad Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US) ,Ortho Clinical Diagnostics, Inc. (US), Becton, Dickinson and Company (US), DiaSorin (Italy), GFE (Germany), Trinity Biotech (Ireland), Merck Millipore (Germany), GE Healthcare (US), Perkin Elmer (US), Bio-Techne Corporation (US), and J Mitra & Co. Pvt. Ltd (India).

"Nucleic Acid Testing (NAT) segment accounted for the larger share of the blood screening market, by technology, in 2018"

The blood screening market, by technology, has been segmented into nucleic acid testing (NAT), enzyme-linked immunosorbent assays (ELISA), rapid tests, western blot assays, and next-generation sequencing (NGS). The NAT segment dominates the blood screening market, by technology, primarily due to the increasing number of blood donations and the increasing adoption of NAT technology due to its higher sensitivity over other blood screening technologies. Based on type, the blood screening market for NAT is segmented into transcription-mediated amplification (TMA) and real-time PCR. Among these, the TMA segment accounts for the larger market share due to the higher sensitivity of this assay.

"Blood banks to register the highest growth in the blood screening market during the forecast period"

Based on end users, the blood screening market is segmented into blood banks and hospitals. The blood bank segment accounted for the larger market share in 2018 and is projected to witness a higher growth rate during the forecast period. This can be attributed to the increasing demand for donated blood, a growing number of organ transplantation surgeries, rising awareness regarding the safety of blood, increasing the number of donations worldwide, and growth in government funding to charitable trusts.

"North America will continue to dominate the blood screening market during the forecast period"

Based on region, the blood screening market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2018, North America accounted for the largest market share, followed by Europe. Factors such as the increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens, the presence of high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the blood screening market in North America.

Place a direct purchase order and get 20% instant discount @ https://www.reportsnreports.com/purchase.aspx?name=345414

Research Coverage:

This report provides a detailed picture of the global blood screening market. It aims at estimating the size and future growth potential of the market across different segments, such as product& service,technology, enduser, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall blood screening market and its sub segments .It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, opportunities, and trends.

List of Tables

Table 1 Global Cancer Incidence, 2018 Vs. 2025
Table 2 Blood Screening Market, By Product & Service, 2018-2024 (USD Million)
Table 3 Blood Screening Reagents & Kits Market, By Country, 2018-2024 (USD Million)
Table 4 Blood Screening Reagents & Kits Market, By Type, 2018-2024 (USD Million)
Table 5 NAT Reagents & Kits Market, By Region, 2018-2024 (USD Million)
Table 6 NAT Reagents & Kits Market, By Type, 2018-2024 (USD Million)
Table 7 Elisa Reagents & Kits Market, By Region, 2018-2024 (USD Million)
Table 8 Elisa Reagents & Kits Market, By Type, 2018-2024 (USD Million)
Table 9 Other Reagents & Kits Market, By Region, 2019-2024 (USD Million)
Table 10 Blood Screening Instruments Market, By Region, 2019-2024 (USD Million)
Table 11 Blood Screening Instruments Market, By Mode of Purchase, 2019-2024 (USD Million)
Table 12 Market for Rental Purchase of Blood Screening Instruments, By Country, 2019-2024 (USD Million)
Table 13 Market for Outright Purchase of Blood Screening Instruments, By Country, 2019-2024 (USD Million)
Table 14 Blood Screening Software & Services Market, By Country, 2019-2024 (USD Million)
Table 15 Blood Screening Market, By Technology, 2017-2024 (USD Million)

Download Sample PDF Pages of Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=345414

List of Figures

Figure 1 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 2 Market Size Estimation: Bottom-Up Approach
Figure 3 Market Size Estimation: Top-Down Approach
Figure 4 Data Triangulation Methodology
Figure 5 Blood Screening Market, By Product & Service, 2019 Vs. 2024 (USD Billion)
Figure 6 Market, By Technology, 2019 Vs. 2024 (USD Billion)
Figure 7 Market, By End User, 2019 Vs. 2024 (USD Billion)
Figure 8 Geographic Outlook: Market
Figure 9 Increasing Prevalence of Chronic & Infectious Diseases to Drive Market Growth
Figure 10 Blood Banks Accounted for the Largest Share in the Asia Pacific in 2018
Figure 11 Reagents and Kits Sub Segment Dominates the Blood Screening Products Market
Figure 12 China to Register the Highest CAGR During the Forecast Period
Figure 13 Rise in HIV-Affected Patient Population, 2000-2018
Figure 14 Reagents & Kits Segment is Expected to Hold the Largest Share of the Market During the Forecast Period
Figure 15 NAT Segment Will Continue to Dominate the Blood Screening Market in 2024
Figure 16 Blood Banks Will Continue to Dominate the Market During the Forecast Period
Figure 17 North America: Market Snapshot
Figure 18 Asia Pacific: Market Snapshot
Figure 19 Key Players Adopted Organic as Well as Inorganic Growth Strategies Between 2016 and 2019
Figure 20 Market Evolution Framework
Figure 21 NAT Blood Screening Market Share Analysis, By Key Player, 2018
Figure 22 Market Share Analysis, By Key Player, 2018
Figure 23 Competitive Leadership Mapping
Figure 24 Grifols: Company Snapshot (2018)
Figure 25 F. Hoffman-La Roche: Company Snapshot (2018)

Connect Us for more information at sales@reportsandreports.com or Call Us + 1 888 391 5441.

About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.